PepsiCo, Inc. KO shares are trading lower by 5.03% to $160.42 going into the close of Thursday's session. Shares are falling amid Walmart indicating that there has been a decrease in shopping demand due to the use of appetite-suppressing medications such as Ozempic and Wegovy. The stock is also falling amid overall market weakness recent strength in Treasury yields.
Pepsi stock is also well-regarded for its dividend payments, often attracting income-focused investors. However, as interest rates increase, fixed-income investments like bonds become more appealing compared to dividend-yielding stocks.
This can lead some investors to shift their investments away from Pepsi, potentially exerting downward pressure on its stock price.
See Also: Coca-Cola Short Seller Says Dominance Fizzles In Face Of Bubbly Upstarts, Weight Loss Drugs
Walmart Reports Decrease In Demand
John Furner, the CEO of Walmart's U.S. operations, confirmed in a recent interview that the company has observed a “slight pullback” in the overall shopping basket of customers using these medications...Read More
According to data from Benzinga Pro, PepsiCo has a 52-week high of $196.88 and a 52-week low of $159.87.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.